Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Tandem Pore Domain | 4 | 2005 | 18 | 0.690 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 2 | 2012 | 13 | 0.580 |
Why?
|
| Insulin | 3 | 2014 | 1226 | 0.520 |
Why?
|
| Ion Channel Gating | 5 | 2013 | 318 | 0.470 |
Why?
|
| Insulin-Secreting Cells | 3 | 2014 | 453 | 0.400 |
Why?
|
| Cyclic GMP | 1 | 2012 | 63 | 0.350 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2012 | 65 | 0.350 |
Why?
|
| Ion Channels | 4 | 2013 | 259 | 0.300 |
Why?
|
| Proinsulin | 1 | 2009 | 123 | 0.300 |
Why?
|
| Potassium Channels | 4 | 2005 | 349 | 0.290 |
Why?
|
| Insulin Resistance | 1 | 2009 | 391 | 0.250 |
Why?
|
| Mutation | 8 | 2013 | 4389 | 0.220 |
Why?
|
| Cell Membrane | 2 | 2005 | 673 | 0.210 |
Why?
|
| Protons | 3 | 2013 | 102 | 0.200 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 41 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 810 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 512 | 0.150 |
Why?
|
| COS Cells | 4 | 2013 | 163 | 0.140 |
Why?
|
| Glucose | 2 | 2012 | 703 | 0.130 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2016 | 7 | 0.120 |
Why?
|
| Zinc | 3 | 2013 | 100 | 0.120 |
Why?
|
| Animals | 11 | 2016 | 28864 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2014 | 3 | 0.110 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 12 | 0.110 |
Why?
|
| Transfection | 3 | 2012 | 883 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 581 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 356 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 412 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2016 | 298 | 0.100 |
Why?
|
| Oocytes | 2 | 2005 | 213 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2012 | 380 | 0.100 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2003 | 115 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2012 | 1285 | 0.090 |
Why?
|
| Stimulation, Chemical | 1 | 2012 | 54 | 0.090 |
Why?
|
| Incretins | 1 | 2012 | 15 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 32 | 0.090 |
Why?
|
| Biotinylation | 1 | 2012 | 43 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2011 | 62 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 139 | 0.090 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 101 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 310 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 325 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 373 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 301 | 0.080 |
Why?
|
| Mice | 4 | 2016 | 12682 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2854 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2012 | 529 | 0.080 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2009 | 30 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 2005 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 731 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2010 | 425 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 2896 | 0.070 |
Why?
|
| Electrophysiology | 2 | 2010 | 389 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2010 | 488 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2009 | 524 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 2011 | 144 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3591 | 0.070 |
Why?
|
| Protein Binding | 3 | 2010 | 1554 | 0.070 |
Why?
|
| Humans | 14 | 2016 | 97913 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 983 | 0.060 |
Why?
|
| Xenopus | 2 | 2003 | 120 | 0.060 |
Why?
|
| Cell Line | 3 | 2010 | 2482 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1286 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 55 | 0.060 |
Why?
|
| Disease Progression | 1 | 2009 | 1607 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2005 | 140 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 89 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2005 | 114 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2005 | 224 | 0.050 |
Why?
|
| Charybdotoxin | 1 | 2003 | 8 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2525 | 0.050 |
Why?
|
| Prokaryotic Cells | 1 | 2003 | 14 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2002 | 10 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 44 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 118 | 0.050 |
Why?
|
| Paralyses, Familial Periodic | 1 | 2002 | 2 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1809 | 0.050 |
Why?
|
| Epilepsy, Absence | 1 | 2002 | 9 | 0.040 |
Why?
|
| Long QT Syndrome | 1 | 2002 | 38 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 401 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 303 | 0.040 |
Why?
|
| Peptides | 1 | 2005 | 669 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2002 | 353 | 0.040 |
Why?
|
| Protein Subunits | 3 | 2010 | 121 | 0.040 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2002 | 123 | 0.040 |
Why?
|
| Membrane Potentials | 3 | 2010 | 406 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2002 | 480 | 0.040 |
Why?
|
| Histidine | 2 | 2011 | 69 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2003 | 571 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 477 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2010 | 1390 | 0.040 |
Why?
|
| Kinetics | 2 | 2010 | 1475 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 6 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 41 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 4071 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 830 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3615 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2014 | 60 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2010 | 923 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 97 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 1145 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 166 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 392 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2014 | 446 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 145 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 34 | 0.020 |
Why?
|
| Sucrose | 1 | 2011 | 63 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2011 | 118 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 98 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 720 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 374 | 0.020 |
Why?
|
| Basophils | 1 | 2010 | 26 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 565 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 181 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 86 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1787 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 149 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2884 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 310 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 381 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 194 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2206 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 443 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1849 | 0.010 |
Why?
|
| Methanococcus | 1 | 2003 | 6 | 0.010 |
Why?
|
| Mesylates | 1 | 2003 | 14 | 0.010 |
Why?
|
| Archaea | 1 | 2003 | 22 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 403 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 28 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2002 | 162 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 581 | 0.010 |
Why?
|
| Cysteine | 1 | 2003 | 149 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 230 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2002 | 103 | 0.010 |
Why?
|
| Female | 2 | 2003 | 51441 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 334 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 548 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1946 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 2222 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 902 | 0.010 |
Why?
|
| Neurons | 1 | 2005 | 1616 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1274 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 2638 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2002 | 2555 | 0.010 |
Why?
|
| Male | 1 | 2014 | 46983 | 0.010 |
Why?
|
| Child | 1 | 2002 | 7687 | 0.000 |
Why?
|
| Adolescent | 1 | 2002 | 10078 | 0.000 |
Why?
|